Senior insider sale
Chief Financial Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$126.9K
3.01K shares
What this filing means
ROBERTS BRANDI plans to sell 3.01K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $126.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006491
Officer· Chief Financial Officer
Since Feb 2026
3.01K
Shares to sell
$126.9K
Approx. market value
3.01K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
6/25/2026
3.01KTotal acquired3.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 3.01K | — |
| Total | 3.01K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.01K
Market value
$126.9K
6/25/2026
Total
Units
3.01K
Value
$126.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2026 | 3.01K | $126.9K | NASDAQ | Planned |
| Total | 3.01K | $126.9K | ||